Suloctidil

CAS No. 54767-75-8

Suloctidil( Suloctidil | Bemperil | Cerebro | Circleton | CP-556S | Daufan | Dulai | Hemoantin | MJF 12637 )

Catalog No. M14970 CAS No. 54767-75-8

Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
5MG 29 In Stock
10MG 42 In Stock
25MG 67 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Suloctidil
  • Note
    Research use only, not for human use.
  • Brief Description
    Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders.
  • Description
    Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Suloctidil | Bemperil | Cerebro | Circleton | CP-556S | Daufan | Dulai | Hemoantin | MJF 12637
  • Pathway
    Others
  • Target
    Platelet aggregation
  • Recptor
    Antiplatelet-aggregation
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    54767-75-8
  • Formula Weight
    337.56
  • Molecular Formula
    C20H35NOS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O[C@@H]([C@@H](NCCCCCCCC)C)C1=CC=C(SC(C)C)C=C1
  • Chemical Name
    (1R,2S)-1-(4-(isopropylthio)phenyl)-2-(octylamino)propan-1-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ishibashi A, et al. Nihon Yakurigaku Zasshi. 1983 Nov;82(5):361-73.
molnova catalog
related products
  • SDZ-62-434

    SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.

  • 48740 RP

    48740 RP is an antagonist of platelet-activating factor.

  • Dextran

    Dextran (Dextran 40) has an inhibitory effect on platelet aggregation and coagulation factors, and is used as an agent for increasing plasma volume.